New Pharma Market Studies by Global Markets Direct Now Available at MarketPublishers.com
13 Jun 2016 • by Natalie Aster
LONDON – Market Publishers Ltd. is very happy to inform you that new Global Markets Direct reports on different receptors’ markets are now available at its online catalogue.
The research reports represent insightful guide to pharma products under discussion. The studies start with detailed overviews of the therapeutics landscape related to each receptor. They proceed with in-depth coverage of targeted therapeutics being under development by various companies and institutions.
The reports throw light on products available in the pipeline, with attention paid to products being on different development stages. The research studies contain detailed profiles of drugs and concentrate on players participating in each marketplace. They also comprise in-depth assessments of targeted therapeutics.
These research reports are sources of valuable data on dormant as well as discontinued pipeline projects. Latest news and information on deals are on hand in the studies, too.
Receptors Examined in the Reports Comprise:
- Histamine H4 Receptor
- Proteinase-Activated Receptor 2
- Melanocyte-Stimulating Hormone Receptor
- Melanocortin Receptor 4
- Melanin-Concentrating Hormone Receptor 1
- Adrenocorticotropic Hormone Receptor
Other Marketplaces Explored by the Publisher Include:
- Head And Neck Cancer Squamous Cell Carcinoma
- Oropharyngeal Cancer
- Gastrointestinal Stromal Tumor (GIST)
More new in-demand studies by Global Markets Direct are available at its page.
Global Markets Direct is a renowned provider of research studies covering different sectors, such as healthcare, energy and power, food processing, and more. Services offered by this publisher comprise: benchmarking expertise, M&A planning, a survey of the competitive environment, company portfolio, to name a few.